Influenza vaccine	Vaccine type	Contraindications	Age range
Live attenuated (Flumist)	Nasal spray	Severe allergy to vaccine or component People 2 to 17 years of age who receive aspirin or salicylate-containing medications Children 2 to 4 years of age with asthma or wheezing in past 12 months Immunosuppressed People who care for severely immunocompromised persons People without a spleen Pregnancy Cerebrospinal fluid leak Cochlear implant Use of influenza antiviral agent within certain amount of time (48 hours for oseltamivir [Tamiflu] and zanamivir [Relenza]; 5 days for peramivir [Rapivab]; 17 days for baloxavir [Xofluza])	2 to 49 years
Quadrivalent (Afluria, Fluarix, Flulaval, Fluzone)	Inactivated	Severe allergy to vaccine or component	≥ 6 months
Quadrivalent cell-based (Flucelvax)	Inactivated	Severe allergy to vaccine or component	≥ 6 months
Quadrivalent (Flucelvax)	Recombinant	Severe allergy to vaccine or component	≥ 18 years
Quadrivalent high-dose (Fluzone)	Inactivated	Severe allergy to vaccine or component	≥ 65 years
Quadrivalent with adjuvant (Fluad)	Inactivated	Severe allergy to vaccine or component	≥ 65 years